Show simple item record

dc.contributor.authorShih, Sophy T F
dc.contributor.authorDavis-Lameloise, Nathalie
dc.contributor.authorJanus, Edward Denis
dc.contributor.authorWildey, Carol
dc.contributor.authorVersace, Vincent L
dc.contributor.authorHagger, Virginia
dc.contributor.authorAsproloupos, Dino
dc.contributor.authorO'Reilly, Sharleen L
dc.contributor.authorPhillips, Paddy Andrew
dc.contributor.authorAckland, Michael
dc.contributor.authorSkinner, Timothy
dc.contributor.authorOats, Jeremy
dc.contributor.authorCarter, Rob
dc.contributor.authorBest, James D
dc.contributor.authorDunbar, James Anthony
dc.date.accessioned2013-12-16T01:58:09Z
dc.date.available2013-12-16T01:58:09Z
dc.date.issued2013-10-17
dc.identifier.citationShih, S., et al., 2013. Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: study protocol for a randomized controlled trial. Trials, 14:339.en
dc.identifier.urihttp://hdl.handle.net/2328/27245
dc.description.abstractBackground: Gestational diabetes mellitus (GDM) is defined as glucose intolerance with its onset or first recognition during pregnancy. Post-GDM women have a life-time risk exceeding 70% of developing type 2 diabetes mellitus (T2DM). Lifestyle modifications reduce the incidence of T2DM by up to 58% for high-risk individuals. Methods/Design: The Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) is a randomized controlled trial aiming to assess the effectiveness of a structured diabetes prevention intervention for post-GDM women. This trial has an intervention group participating in a diabetes prevention program (DPP), and a control group receiving usual care from their general practitioners during the same time period. The 12- month intervention comprises an individual session followed by five group sessions at two-week intervals, and two follow-up telephone calls. A total of 574 women will be recruited, with 287 in each arm. The women will undergo blood tests, anthropometric measurements, and self-reported health status, diet, physical activity, quality of life, depression, risk perception and healthcare service usage, at baseline and 12 months. At completion, primary outcome (changes in diabetes risk) and secondary outcome (changes in psychosocial and quality of life measurements and in cardiovascular disease risk factors) will be assessed in both groups. Discussion: This study aims to show whether MAGDA-DPP leads to a reduction in diabetes risk for post-GDM women. The characteristics that predict intervention completion and improvement in clinical and behavioral measures will be useful for further development of DPPs for this populationen
dc.description.sponsorshipThe study was funded by a Partnerships for Better Health Grant from the National Health and Medical Research Council (grant number 533956) with financial and in-kind contributions from the Victoria State Government, South Australia State Government and Diabetes Australia Victoria.en
dc.language.isoen
dc.publisherBioMed Central Ltd.en
dc.relationhttp://purl.org/au-research/grants/nhmrc/533819en
dc.relationhttp://purl.org/au-research/grants/nhmrc/533956
dc.rightsThis is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.subjectDiabetesen
dc.titleMothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: study protocol for a randomized controlled trialen
dc.typeArticleen
dc.relation.grantnumberNHMRC/533819en
dc.relation.grantnumberNHMRC/533956en
dc.identifier.doihttps://doi.org/10.1186/1745-6215-14-339en
dc.rights.holder© 2013 Shih et al.; licensee BioMed Central Ltd.en
dc.rights.licenseCC-BY


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record